1. Synta Pharmaceuticals Corporation (30 from 162 patents)

2. The University of Texas System (2 from 5,463 patents)

3. Houston Pharmaceuticals, Inc. (2 from 3 patents)

4. Other (1 from 832,880 patents)

1. 9090569 - Triazone compounds that modulate HSP90 activity

2. 8901308 - Triazole compounds that modulate Hsp90 activity

3. 8524712 - Triazinone and diazinone derivatives useful as HSP90 inhibitors

4. 8415377 - Triazole compounds that modulate HSP90 activity

5. 8362055 - Triazole compounds that modulate HSP90 activity

6. 8329736 - Triazole compounds that modulate HSP90 activity

7. 8318730 - Fused hetrocyclic compounds

8. 8318790 - Triazole compounds that modulate HSP90 activity

9. 8299107 - Triazole compounds that modulate HSP90 activity

10. 8236795 - IL-12 modulatory compounds

11. 8183384 - Triazole compounds that modulate HSP90 activity

12. 8173651 - Pyridine compounds

13. 8093425 - Compounds for treating proliferative disorders

14. 8053456 - Triazole compounds that modulate Hsp90 activity

15. 7825148 - Triazole compounds that modulate Hsp90 activity